Skip to main content

Table 3 Findings of studies on HBV prevalence among non-injecting people who use drugs in Irana

From: Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis

No Author, year Recruitment setting Age characteristics History of incarceration (%) Sample size (Male, Female) HBsAg positive cases (%)
Total Male Female
1 Moradi, 2019 [49] Incarcerated NA 3917 (UK) 120 (3.0)
2 Moradi, 2018 [50] Incarcerated NA 3400 (UK) 95 (2.8)
3 Ziaee, 2016 [51] Community 139 (UK) 5 (3.6)
4 Mohammadkhani-Ghiasvand, 2016 [56] DTC 186 (UK) 3 (1.3)
5 Teimori, 2011 [59] DTC Mean: 35.2
Range: 20–54
1.3 66 (0, 66) 0 (0) 0 (0)
6 Nokhodian, 2012 [63] Incarcerated 44 (0, 44) 0 (0) 0 (0)
7 Khajedaluee, 2016 [65] Incarcerated 495 (UK) 16 (3.2)
8 Mardani, 2009 [70] Incarcerated 164 (UK) 6 (3.7)
9 Talaei, 2007 [71] Hospital 126 (UK) 2 (1.6)
10 Azarkar, 2007 [73] Incarcerated 140 (UK) 6 (4.3)
11 Khodadadizadeh, 2006 [75] DTC 149 (141, 8) 2 (3.7) 1 (0.7) 1 (12.5)
  1. NA not applicable, UK unknown, DTC drug treatment center  
  2. aNo study reported data on the history of high-risk sexual relationships, tattooing, cupping and co-infection with HCV or HIV